A propensity score-matched comparison between Cardia and Amplatzer PFO closure devices - insights from the SOLUTION registry (Swiss percutaneOus patent foramen ovale cLosUre in recurrent clinical events prevenTION)

Serban Puricel1, MD; Diego Arroyo1, MD; Jean-Jacques Goy1,2, MD; Fabien Praz3, MD; Nuno Palhais1, MD; Andreas Wahl3, MD; Jean-Christophe Stauffer1, MD; Mario Togni1, MD; Alexandre Berger2, MD; Bernhard Meier3, MD; Stéphane Cook1*, MD

1. The University Hospital Fribourg, Fribourg, Switzerland; 2. The Cecil Clinic, Lausanne, Switzerland; 3. The University Hospital Bern, Bern, Switzerland

Aims: To compare clinical outcome of Amplatzer PFO (APFO) to Cardia PFO (CPFO) occluder. Percutaneous patent foramen ovale (PFO) closure prevents stroke recurrence in stroke due to parado

Sign in to read and download the full article

Login Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

cryptogenic strokepatent foramen ovalepfo occluderrecurrent neurological event

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Device embolisation after transcatheter paravalvular leak closure